Gladstone Institutional Advisory’s Boston Scientific BSX Stock Holding History

Gladstone Institutional Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$868K	Sell	13,838 -32,662	-70%	-$2.61M	0.03%	396
2025 Q4	$4.43M	Sell	46,500 -5,384	-10%	-$528K	0.17%	134
2025 Q3	$5.07M	Buy	51,884 +14,700	+40%	+$1.52M	0.2%	111
2025 Q2	$3.99M	Buy	37,184 +15,963	+75%	+$1.62M	0.17%	142
2025 Q1	$2.14M	Buy	21,221 +14,680	+224%	+$1.48M	0.1%	218
2024 Q4	$584K	Sell	6,541 -558	-8%	-$49.1K	0.03%	435
2024 Q3	$595K	Sell	7,099 -198	-3%	-$15.6K	0.03%	408
2024 Q2	$562K	Buy	7,297 +80	+1%	+$5.86K	0.03%	403
2024 Q1	$494K	Buy	7,217 +3,077	+74%	+$198K	0.03%	411
2023 Q4	$239K	Buy	+4,140	New	+$221K	0.01%	577
2022 Q3	–	Sell	-6,929	Closed	-$258K	–	635
2022 Q2	$258K	Sell	6,929 -1,691	-20%	-$68.8K	0.02%	543
2022 Q1	$382K	Sell	8,620 -2,874	-25%	-$125K	0.03%	489
2021 Q4	$488K	Buy	11,494 +500	+5%	+$21K	0.04%	385
2021 Q3	$477K	Buy	10,994 +5,787	+111%	+$256K	0.05%	337
2021 Q2	$223K	Buy	+5,207	New	+$219K	0.03%	467

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gladstone Institutional Advisory's BSX Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its Boston Scientific (BSX) stake by 70% in Q1 2026, selling an estimated $2.61M and leaving 13,838 shares worth $868K. The position accounts for 0.03% of the portfolio, ranked #396.

Gladstone Institutional Advisory first reported a position in BSX in Q2 2021 and has held it in 15 quarters since. The position peaked at $5.07M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Gladstone Institutional Advisory held 13,838 shares of Boston Scientific worth $868K as of Q1 2026.
Gladstone Institutional Advisory sold 32,662 Boston Scientific shares in Q1 2026, an estimated $2.61M.
Boston Scientific made up 0.03% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #396 holding.
Gladstone Institutional Advisory first reported a position in Boston Scientific in Q2 2021 and has held it in 15 quarters since.
Gladstone Institutional Advisory's Boston Scientific position peaked at $5.07M in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.